期刊文献+

观察缬沙坦在充血性心力衰竭中的治疗作用 被引量:1

Observation on the therapeutic effects of valsartan in the treatment of congestive heart failure
下载PDF
导出
摘要 目的观察缬沙坦在充血性心力衰竭中的治疗作用。方法60例充血性心力衰竭患者随机分为观察组30例和对照组30例。对照组应用洋地黄及利尿剂,观察组在此基础上加用结沙坦。治疗前后采用多普勒超声心动图测定心功能。结果治疗后观察组左室舒张期末内径显著低于对照组;左室射血分数显著高于对照组(P<0.01)。结论在常规药物洋地黄及利尿剂的基础上加用缬沙坦治疗慢性心力衰竭有效,可以改善心脏功能。 Objective To observation the effect of valsartan in the treatment of congestive heart failure (CHF). Methods 60 patients with congestive heart failure were divided randomly into two groups, one was control group treated with digoxin and diuretic, and another was observation group treated with valsartan on rhe basis of above regular treatment. All the patients were measured the heart function by echocardiography before and after the treatment. Results After valsartan treatment,LVEDD were smaller than that in control group,LVEF was higher than that in control group( P 〈0.01 ). Conclusion Valsartan medication is a effective method in the treatment of chronic heart failure on the basis of above regular treatment,can improve the heart function.
出处 《临床和实验医学杂志》 2008年第12期64-65,共2页 Journal of Clinical and Experimental Medicine
关键词 缬沙坦 心力衰竭 充血性 治疗 Valsartan Heart failure Congestive Treatment
  • 相关文献

参考文献5

二级参考文献19

  • 1孙广辉.影响充血性心力衰竭病人的预后因素[J].心血管病学进展,1994,15(3):144-148. 被引量:12
  • 2李楚杰 卢兴 等.临床病理生学(下册,第1版)[M].广东科技出版社,1990.238-258.
  • 3Beta - Blocker Evaluation of Survival Trial Investigators. A trial of the beta - blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med, 2001,344:1659- 1667.
  • 4Bristow MR. Adrenergie receptor blockade in chronic heart failure. Circulation, 2000, 101:558 - 569.
  • 5Heart Failure Society d America. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction -pharmacological approaches. Pharmacotherapy, 2000, 20:495 - 522.
  • 6Pitt B, Zannad F, Remme WJ, et al. The effect d spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med, 1999, 341(10) :709 - 717.
  • 7Cicoira M, ZanoUa L, Roesi A, et al. Long- term, dose - dependent effects of spironolactone on left ventricular function and exercise telerance in patients with chronic heart failure. J Am Coll Cardiol, 2002,40(2) :304 - 310.
  • 8Pitt B, Poole - Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Lossrtan Heart Failure Survival Study ELITE Ⅱ. Lancet, 2000,355(9215) :1582 - 1587.
  • 9Cohn JN, Tognoni G. A randomized trial of the angiotensin - receptor blocker valsartan in chronic heart failure. N Engl J Med, 2001, 345(23) :1667 - 75.
  • 10The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Meal, 1997,336(8) :525 - 33.

共引文献2423

同被引文献2

  • 1牛晓红 刘晓梅 柳洲.血管紧张素Ⅱ受体在心血管疾病中的进展.心血管病学进展,2002,22(04):676-678.
  • 2刘景华,刘晓梅,牛晓红,王春芳.充血性心力衰竭的治疗进展[J].医学信息(医学与计算机应用),2001,14(6):357-358. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部